Altered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivators

Abstract Background We previously developed drug-like peptide triazoles (PTs) that target HIV-1 Envelope (Env) gp120, potently inhibit viral entry, and irreversibly inactivate virions. Here, we investigated potential mechanisms of viral escape from this promising class of HIV-1 entry inhibitors. Res...

Full description

Bibliographic Details
Main Authors: Shiyu Zhang, Andrew P. Holmes, Alexej Dick, Adel A. Rashad, Lucía Enríquez Rodríguez, Gabriela A. Canziani, Michael J. Root, Irwin M. Chaiken
Format: Article
Language:English
Published: BMC 2021-10-01
Series:Retrovirology
Subjects:
Online Access:https://doi.org/10.1186/s12977-021-00575-z
_version_ 1818908717701136384
author Shiyu Zhang
Andrew P. Holmes
Alexej Dick
Adel A. Rashad
Lucía Enríquez Rodríguez
Gabriela A. Canziani
Michael J. Root
Irwin M. Chaiken
author_facet Shiyu Zhang
Andrew P. Holmes
Alexej Dick
Adel A. Rashad
Lucía Enríquez Rodríguez
Gabriela A. Canziani
Michael J. Root
Irwin M. Chaiken
author_sort Shiyu Zhang
collection DOAJ
description Abstract Background We previously developed drug-like peptide triazoles (PTs) that target HIV-1 Envelope (Env) gp120, potently inhibit viral entry, and irreversibly inactivate virions. Here, we investigated potential mechanisms of viral escape from this promising class of HIV-1 entry inhibitors. Results HIV-1 resistance to cyclic (AAR029b) and linear (KR13) PTs was obtained by dose escalation in viral passaging experiments. High-level resistance for both inhibitors developed slowly (relative to escape from gp41-targeted C-peptide inhibitor C37) by acquiring mutations in gp120 both within (Val255) and distant to (Ser143) the putative PT binding site. The similarity in the resistance profiles for AAR029b and KR13 suggests that the shared IXW pharmacophore provided the primary pressure for HIV-1 escape. In single-round infectivity studies employing recombinant virus, V255I/S143N double escape mutants reduced PT antiviral potency by 150- to 3900-fold. Curiously, the combined mutations had a much smaller impact on PT binding affinity for monomeric gp120 (four to ninefold). This binding disruption was entirely due to the V255I mutation, which generated few steric clashes with PT in molecular docking. However, this minor effect on PT affinity belied large, offsetting changes to association enthalpy and entropy. The escape mutations had negligible effect on CD4 binding and utilization during entry, but significantly altered both binding thermodynamics and inhibitory potency of the conformationally-specific, anti-CD4i antibody 17b. Moreover, the escape mutations substantially decreased gp120 shedding induced by either soluble CD4 or AAR029b. Conclusions Together, the data suggest that the escape mutations significantly modified the energetic landscape of Env’s prefusogenic state, altering conformational dynamics to hinder PT-induced irreversible inactivation of Env. This work therein reveals a unique mode of virus escape for HIV-1, namely, resistance by altering the intrinsic conformational dynamics of the Env trimer.
first_indexed 2024-12-19T22:15:27Z
format Article
id doaj.art-f6b48e73585849659ae886b813db588b
institution Directory Open Access Journal
issn 1742-4690
language English
last_indexed 2024-12-19T22:15:27Z
publishDate 2021-10-01
publisher BMC
record_format Article
series Retrovirology
spelling doaj.art-f6b48e73585849659ae886b813db588b2022-12-21T20:03:47ZengBMCRetrovirology1742-46902021-10-0118111810.1186/s12977-021-00575-zAltered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivatorsShiyu Zhang0Andrew P. Holmes1Alexej Dick2Adel A. Rashad3Lucía Enríquez Rodríguez4Gabriela A. Canziani5Michael J. Root6Irwin M. Chaiken7Department of Biochemistry and Molecular Biology, Drexel University College of MedicineDepartment of Biochemistry and Molecular Biology, Drexel University College of MedicineDepartment of Biochemistry and Molecular Biology, Drexel University College of MedicineDepartment of Biochemistry and Molecular Biology, Drexel University College of MedicineFaculty of Experimental Science, Francisco de Vitoria UniversityDepartment of Biochemistry and Molecular Biology, Drexel University College of MedicineDepartment of Microbial Infection and Immunity, The Ohio State University College of MedicineDepartment of Biochemistry and Molecular Biology, Drexel University College of MedicineAbstract Background We previously developed drug-like peptide triazoles (PTs) that target HIV-1 Envelope (Env) gp120, potently inhibit viral entry, and irreversibly inactivate virions. Here, we investigated potential mechanisms of viral escape from this promising class of HIV-1 entry inhibitors. Results HIV-1 resistance to cyclic (AAR029b) and linear (KR13) PTs was obtained by dose escalation in viral passaging experiments. High-level resistance for both inhibitors developed slowly (relative to escape from gp41-targeted C-peptide inhibitor C37) by acquiring mutations in gp120 both within (Val255) and distant to (Ser143) the putative PT binding site. The similarity in the resistance profiles for AAR029b and KR13 suggests that the shared IXW pharmacophore provided the primary pressure for HIV-1 escape. In single-round infectivity studies employing recombinant virus, V255I/S143N double escape mutants reduced PT antiviral potency by 150- to 3900-fold. Curiously, the combined mutations had a much smaller impact on PT binding affinity for monomeric gp120 (four to ninefold). This binding disruption was entirely due to the V255I mutation, which generated few steric clashes with PT in molecular docking. However, this minor effect on PT affinity belied large, offsetting changes to association enthalpy and entropy. The escape mutations had negligible effect on CD4 binding and utilization during entry, but significantly altered both binding thermodynamics and inhibitory potency of the conformationally-specific, anti-CD4i antibody 17b. Moreover, the escape mutations substantially decreased gp120 shedding induced by either soluble CD4 or AAR029b. Conclusions Together, the data suggest that the escape mutations significantly modified the energetic landscape of Env’s prefusogenic state, altering conformational dynamics to hinder PT-induced irreversible inactivation of Env. This work therein reveals a unique mode of virus escape for HIV-1, namely, resistance by altering the intrinsic conformational dynamics of the Env trimer.https://doi.org/10.1186/s12977-021-00575-zHIV-1Envelope glycoproteinsEntry inhibitorResistance mechanismgp120 sheddingVirus escape
spellingShingle Shiyu Zhang
Andrew P. Holmes
Alexej Dick
Adel A. Rashad
Lucía Enríquez Rodríguez
Gabriela A. Canziani
Michael J. Root
Irwin M. Chaiken
Altered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivators
Retrovirology
HIV-1
Envelope glycoproteins
Entry inhibitor
Resistance mechanism
gp120 shedding
Virus escape
title Altered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivators
title_full Altered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivators
title_fullStr Altered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivators
title_full_unstemmed Altered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivators
title_short Altered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivators
title_sort altered env conformational dynamics as a mechanism of resistance to peptide triazole hiv 1 inactivators
topic HIV-1
Envelope glycoproteins
Entry inhibitor
Resistance mechanism
gp120 shedding
Virus escape
url https://doi.org/10.1186/s12977-021-00575-z
work_keys_str_mv AT shiyuzhang alteredenvconformationaldynamicsasamechanismofresistancetopeptidetriazolehiv1inactivators
AT andrewpholmes alteredenvconformationaldynamicsasamechanismofresistancetopeptidetriazolehiv1inactivators
AT alexejdick alteredenvconformationaldynamicsasamechanismofresistancetopeptidetriazolehiv1inactivators
AT adelarashad alteredenvconformationaldynamicsasamechanismofresistancetopeptidetriazolehiv1inactivators
AT luciaenriquezrodriguez alteredenvconformationaldynamicsasamechanismofresistancetopeptidetriazolehiv1inactivators
AT gabrielaacanziani alteredenvconformationaldynamicsasamechanismofresistancetopeptidetriazolehiv1inactivators
AT michaeljroot alteredenvconformationaldynamicsasamechanismofresistancetopeptidetriazolehiv1inactivators
AT irwinmchaiken alteredenvconformationaldynamicsasamechanismofresistancetopeptidetriazolehiv1inactivators